Hyperfine (NASDAQ:HYPR) Stock Rating Lowered by Wall Street Zen

Hyperfine (NASDAQ:HYPR) was downgraded by equities researchers at Wall Street Zen from a “hold” rating to a “sell” rating in a report released on Saturday, Wall Street Zen reports.

HYPR has been the topic of a number of other research reports. Loop Capital set a $2.00 price objective on Hyperfine in a research note on Tuesday, October 27th. Lucid Cap Mkts assumed coverage on Hyperfine in a report on Tuesday, October 27th. They issued a “strong-buy” rating on the stock. Weiss Ratings restated a “sell (d-)” rating on shares of Hyperfine in a research report on Thursday, October 15th. B. Riley Financial reaffirmed a “buy” rating and set a $1.60 price objective (down from $2.00) on shares of Hyperfine in a research report on Monday, August 10th. Finally, BTIG Research restated a “buy” rating and issued a $2.00 price target on shares of Hyperfine in a research note on Tuesday, September 22nd. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $2.02.

Hyperfine Stock Performance

Shares of Hyperfine stock opened at $0.72 on Friday. The business has a 50-day simple moving average of $0.81 and a 200-day simple moving average of $1.12. The company has a debt-to-equity ratio of 0.36, a quick ratio of 5.45 and a current ratio of 6.15. Hyperfine has a one year low of $0.70 and a one year high of $1.94. The company has a market cap of $76.36 million, a PE ratio of -1.89 and a beta of 1.50.

Hyperfine (NASDAQ:HYPR) last announced its quarterly earnings data on Thursday, August 6th. The company reported ($0.09) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.09). The firm had revenue of $3.90 million for the quarter, compared to analyst estimates of $4.13 million. Hyperfine had a negative return on equity of 97.88% and a negative net margin of 210.75%. On average, equities research analysts forecast that Hyperfine will post -0.34 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of HYPR. Renaissance Technologies LLC boosted its position in shares of Hyperfine by 100.2% during the 1st quarter. Renaissance Technologies LLC now owns 730,233 shares of the company’s stock valued at $789,000 after acquiring an additional 365,490 shares during the last quarter. Bank of New York Mellon Corp acquired a new stake in Hyperfine during the 2nd quarter worth about $419,000. Walleye Capital LLC raised its holdings in shares of Hyperfine by 3.4% during the first quarter. Walleye Capital LLC now owns 223,988 shares of the company’s stock worth $242,000 after purchasing an additional 7,330 shares during the last quarter. Finally, PFS Partners LLC grew its stake in shares of Hyperfine by 150.0% during the 3rd quarter. PFS Partners LLC now owns 50,000 shares of the company’s stock worth $40,000 after purchasing an additional 30,000 shares during the period. Hedge funds and other institutional investors own 15.03% of the company’s stock.

About Hyperfine

Hyperfine, Inc (NASDAQ: HYPR) is a medical technology company focused on making magnetic resonance imaging more accessible and convenient. The company develops portable, low-field MRI technology designed to bring brain imaging directly to patients in locations such as intensive care units, emergency departments, operating rooms and other point-of-care settings.

Hyperfine’s primary product is the Swoop Portable MR Imaging System, a compact MRI platform that can be moved to a patient’s bedside.